BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12867010)

  • 21. Multiple competing interests surround ethical review of clinical trials.
    Henderson D
    Intern Med J; 2005 Nov; 35(11):686-7. PubMed ID: 16248869
    [No Abstract]   [Full Text] [Related]  

  • 22. The conduct of successful multi-site EU collaborative research: the EPSILON Study.
    Thornicroft G; Becker T; Knapp M; Knudsen HC; Schene A; Tansella M; Vazquez-Barquero JL;
    Epidemiol Psichiatr Soc; 2002; 11(1):2-5. PubMed ID: 12043429
    [No Abstract]   [Full Text] [Related]  

  • 23. European move affects academic trials research.
    Sinha G
    J Natl Cancer Inst; 2006 Aug; 98(16):1100-1. PubMed ID: 16912258
    [No Abstract]   [Full Text] [Related]  

  • 24. Site qualification in multicenter clinical trials.
    McEwan AS; Graham MM; Conti PS
    J Nucl Med; 2009 Aug; 50(8):30N. PubMed ID: 19652215
    [No Abstract]   [Full Text] [Related]  

  • 25. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
    Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
    Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Of course patients should be told.
    Goodare H
    BMJ; 2002 Feb; 324(7334):420-1. PubMed ID: 11855387
    [No Abstract]   [Full Text] [Related]  

  • 27. Multicentre analysis of treatment planning information: technical requirements, possible applications and a proposal.
    Ebert MA; Blight J; Price S; Haworth A; Hamilton C; Cornes D; Joseph DJ
    Australas Radiol; 2004 Sep; 48(3):347-52. PubMed ID: 15344985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?
    Mano MS; Rosa DD; Dal Lago L
    Eur J Cancer; 2006 Nov; 42(16):2675-7. PubMed ID: 16962315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
    Ryan JM; Schneider G; Jacobsen JS
    Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445
    [No Abstract]   [Full Text] [Related]  

  • 30. The surgeon is only one factor.
    Treasure T
    BMJ; 2002 Feb; 324(7334):421. PubMed ID: 11855388
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of oral mucositis in clinical trials: impact of training on evaluators in a multi-centre trial.
    Stokman MA; Sonis ST; Dijkstra PU; Burgerhof JG; Spijkervet FK
    Eur J Cancer; 2005 Aug; 41(12):1735-8. PubMed ID: 16039109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel approach to rater training and certification in multinational trials.
    Jeglic E; Kobak KA; Engelhardt N; Williams JB; Lipsitz JD; Salvucci D; Bryson H; Bellew K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):187-91. PubMed ID: 17519640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central IRBs: why are some institutions reluctant to sign on?
    McNeil C
    J Natl Cancer Inst; 2005 Jul; 97(13):953-5. PubMed ID: 15998943
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethics committee reviews and mutual acceptance: a pilot study.
    Rosenthal MA; Sarson-Lawrence M; Alt C; Arkell K; Dodds M;
    Intern Med J; 2005 Nov; 35(11):650-4. PubMed ID: 16248858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Registries for clinical trials -- a critical stock-taking].
    Bestehorn K; Hönig R; Clemens N; Kirch W
    Med Klin (Munich); 2006 Feb; 101(2):120-6. PubMed ID: 16501909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studies.
    Cohen J; Cutter G; Lublin F; Schwid S
    Mult Scler; 2004 Jun; 10(3):332-3. PubMed ID: 15222702
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical trials in Norway--completion and reporting are not satisfactory].
    Sandaker L; Fjeld B; Reikvam A; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2888-90. PubMed ID: 15550958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rater training in multicenter clinical trials: issues and recommendations.
    Kobak KA; Engelhardt N; Williams JB; Lipsitz JD
    J Clin Psychopharmacol; 2004 Apr; 24(2):113-7. PubMed ID: 15206656
    [No Abstract]   [Full Text] [Related]  

  • 40. Quality assurance issues in conducting multi-institutional advanced technology clinical trials.
    Purdy JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S66-70. PubMed ID: 18406941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.